Key regions: China, South Korea, Canada, India, France
The Analgesics (Pharmacies) market in Zimbabwe is experiencing steady growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Analgesics (Pharmacies) market in Zimbabwe are shifting towards more natural and herbal remedies. Customers are becoming increasingly conscious of the potential side effects of traditional analgesics and are seeking alternative options. This preference for natural remedies is driving the demand for herbal analgesics and creating opportunities for new players in the market. Trends in the Analgesics (Pharmacies) market in Zimbabwe include the rise of e-commerce and online pharmacies. With the increasing penetration of smartphones and internet connectivity, customers are increasingly turning to online platforms to purchase their analgesics. This trend is driven by the convenience and accessibility of online shopping, as well as the availability of a wider range of products. Online pharmacies are also able to offer competitive prices, further attracting customers away from traditional brick-and-mortar pharmacies. Local special circumstances in Zimbabwe, such as the high prevalence of chronic pain conditions and the limited availability of healthcare services, are contributing to the growth of the Analgesics (Pharmacies) market. Zimbabwe has a high burden of non-communicable diseases, including conditions that cause chronic pain such as arthritis and cancer. As a result, there is a constant demand for analgesics to manage these conditions. Additionally, the limited availability of healthcare services in some areas of the country makes pharmacies the primary source of healthcare for many Zimbabweans. Underlying macroeconomic factors, such as population growth and increasing disposable incomes, are also driving the growth of the Analgesics (Pharmacies) market in Zimbabwe. The country's population is growing steadily, resulting in a larger customer base for pharmacies. Furthermore, as disposable incomes increase, more people are able to afford analgesics and are willing to spend on healthcare products. In conclusion, the Analgesics (Pharmacies) market in Zimbabwe is developing in response to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural remedies, the rise of e-commerce, the high prevalence of chronic pain conditions, and population growth with increasing disposable incomes all contribute to the growth of the market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
